Introduction Glucagon-like peptide-1 receptor agonists (GLP-1RA) are effective therapies for patients with type 2 diabetes (T2D) and/or obesity, particularly for those with coexisting cardiovascular disease and/or high cardiovascular risk [1]
This presents a major financial barrier for patients who cannot afford thousands of dollars upfront, even if it saves them money over the course of a year
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every single cell in your body
W badaniach nad gojeniem oba peptydy operuj na rnych poziomach tego samego procesu jeden chroni i odbudowuje lokalnie, drugi mobilizuje komrki naprawcze szeroko
Introduction palpable, distended, tortuous, subcutaneous veins involved vessels Etiology primary (e.g., primary venous disease) secondary (e.g., previous deep vein thrombosis) congenital (e.g., Klippel-Trenaunay syndrome) Pathogenesis may be due to valve incompetence, leading to venous hypertension Epidemiology risk factors more common in women than in men Presentation Symptoms may be asymptomatic or may describe calf heaviness/swelling Physical exam palpable, distended, tortuous, subcutaneous veins Evaluation Clinical diagnosis Duplex ultrasound Differential Diagnosis Reticular veins Telangiectasias Treatment Compression therapy can accompany leg elevation and exercise Vein ablation therapy Prognosis, Prevention, and Complications Prognosis in untreated patients Complications skin changes/venous ulcers may develop complications after certain procedures
